BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8039158)

  • 21. Secondary acute leukemia and myelodysplastic syndrome with 11q23 abnormalities. EU Concerted Action 11q23 Workshop.
    Secker-Walker LM; Moorman AV; Bain BJ; Mehta AB
    Leukemia; 1998 May; 12(5):840-4. PubMed ID: 9593290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Childhood acute lymphoblastic leukemia with both t(1;19) and t(9;22).
    Griffin TC; Tomlinson GE; Raimondi SC; Sandoval C; Timmons CF; Rosenfield C; Carroll AJ; Schneider NR
    Leukemia; 1992 Jun; 6(6):535-40. PubMed ID: 1602792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
    Jang GD; Kim SW; Suh CW; Kim EK; Bahng HS; Jeong YH; Park IG; Kim WK; Kim SH; Suh EJ; Park CJ; Ji HS; Lee JS
    J Korean Med Sci; 2002 Aug; 17(4):555-9. PubMed ID: 12172056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements.
    Andersen MK; Johansson B; Larsen SO; Pedersen-Bjergaard J
    Haematologica; 1998 Jun; 83(6):483-8. PubMed ID: 9676019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
    Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
    J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy.
    Rubin CM; Arthur DC; Woods WG; Lange BJ; Nowell PC; Rowley JD; Nachman J; Bostrom B; Baum ES; Suarez CR
    Blood; 1991 Dec; 78(11):2982-8. PubMed ID: 1954385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Childhood myeloid leukaemias.
    Hall GW
    Best Pract Res Clin Haematol; 2001 Sep; 14(3):573-91. PubMed ID: 11640870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
    Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
    Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26).
    Fonatsch C; Gudat H; Lengfelder E; Wandt H; Silling-Engelhardt G; Ludwig WD; Thiel E; Freund M; Bodenstein H; Schwieder G
    Leukemia; 1994 Aug; 8(8):1318-26. PubMed ID: 8057667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
    Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E
    P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
    Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
    Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome.
    Li S; Yin CC; Medeiros LJ; Bueso-Ramos C; Lu G; Lin P
    Am J Clin Pathol; 2012 Jul; 138(1):146-52. PubMed ID: 22706870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2).
    Wang HY; Rashidi HH
    Arch Pathol Lab Med; 2016 Dec; 140(12):1404-1410. PubMed ID: 27628325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translocation (1;11)(q23;p15), a novel simple variant of translocation (7;11)(p15;p15), in a patient with AML (M2) accompanied by non-Hodgkin lymphoma and gastric cancer.
    Hatano Y; Miura I; Kume M; Miura AB
    Cancer Genet Cytogenet; 2000 Feb; 117(1):19-23. PubMed ID: 10700860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia.
    Lin P; Medeiros LJ; Yin CC; Abruzzo LV
    Cancer Genet Cytogenet; 2006 Apr; 166(1):82-5. PubMed ID: 16616115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study.
    Secker-Walker LM; Mehta A; Bain B
    Br J Haematol; 1995 Oct; 91(2):490-501. PubMed ID: 8547101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.
    Langer T; Metzler M; Reinhardt D; Viehmann S; Borkhardt A; Reichel M; Stanulla M; Schrappe M; Creutzig U; Ritter J; Leis T; Jacobs U; Harbott J; Beck JD; Rascher W; Repp R
    Genes Chromosomes Cancer; 2003 Apr; 36(4):393-401. PubMed ID: 12619163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
    Pedersen-Bjergaard J; Philip P; Larsen SO; Andersson M; Daugaard G; Ersbøll J; Hansen SW; Hou-Jensen K; Nielsen D; Sigsgaard TC
    Leukemia; 1993 Dec; 7(12):1975-86. PubMed ID: 8255096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversioin inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26).
    Reiter E; Greinix H; Rabitsch W; Keil F; Schwarzinger I; Jaeger U; Lechner K; Worel N; Streubel B; Fonatsch C; Mitterbauer G; Kalhs P
    Ann Hematol; 2000 Jul; 79(7):374-7. PubMed ID: 10965785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy-related myeloid leukemia.
    Thirman MJ; Larson RA
    Hematol Oncol Clin North Am; 1996 Apr; 10(2):293-320. PubMed ID: 8707757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.